Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Share-based Compensation (2016 - 2025)

MedWellAI (MWAI) has disclosed Share-based Compensation for 9 consecutive years, with $162500.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation changed 0.0% to $162500.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $763167.0 through Dec 2025, up 369.64% year-over-year, with the annual reading at $599542.0 for FY2025, N/A changed from the prior year.
  • Share-based Compensation for Q4 2025 was $162500.0 at MedWellAI, up from $49250.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $14.8 million in Q2 2023, with the low at -$8.3 million in Q4 2023.
  • Average Share-based Compensation over 5 years is $1.4 million, with a median of $162500.0 recorded in 2024.
  • Peak annual rise in Share-based Compensation hit 3900.0% in 2023, while the deepest fall reached 5824.14% in 2023.
  • Over 5 years, Share-based Compensation stood at $1.9 million in 2021, then plummeted by 92.29% to $145000.0 in 2022, then tumbled by 5824.14% to -$8.3 million in 2023, then skyrocketed by 101.96% to $162500.0 in 2024, then changed by 0.0% to $162500.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $162500.0, $49250.0, and $49250.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.